DIRS.INFO top alerts submit data jurnalism about API
login
Top related persons:
Richard A - 1 Gonzalez - 1 Pascal Soriot - 1 Giovanni Caforio - 1 Jennifer Taubert - 1 Johnson - 1 Kenneth C - 1 Frazier - 1
Top related locs:
America Washington , DC Bristol U.S Washington , Southern District Southern District of Ohio New Jersey
Top related orgs:
Senate - 1 AbbVie Inc - 1 AstraZeneca - 1 Myers Squibb Co - 1 Janssen Pharmaceuticals - 1 Johnson - 1 Merck & Co - 1 Inc - 1

Search resuls for: "Chris Meekins"


2 mentions found


☆ Drugmakers aim to strike down Medicare drug-price negotiations at Supreme Court
  + stars: | 2023-06-20 | by ( Spencer Kimball | ) www.cnbc.com   time to read: +10 min
And Bristol Myers Squibb is trying protect its blood thinner Eliquis, which brought in $11.8 billion in sales last year, or about 25% of the company's $46 billion total revenue for 2022. Long legal battle aheadMerck, the chamber and Bristol Myers Squibb filed their lawsuits ahead of two key deadlines. Bristol Myers Squibb did not either. If circuit court decisions on the matter contradict one another, the Supreme Court would step in to decide the issue, Bagby said. Bristol Myers Squibb made an identical argument in its complaint.
Persons: Richard A, Gonzalez, Pascal Soriot, Giovanni Caforio, Jennifer Taubert, Johnson, Kenneth C, Frazier, Albert Bourla, Olivier Brandicourt, Win Mcnamee, Drugmaker Merck, Drugmaker, Bristol Myers Squibb, PhRMA, Eli Lilly, Merck, Bristol Myers, Robin Feldman, Nicholas Bagley, Bagley, Gretchen Whitmer, Chris Meekins, Raymond James, Antonin Scalia, Brett Kavanaugh, Neil Gorsuch, Meekins, Long, Xavier Becerra, Randolph Daniel Moss, Barack Obama, Judge Thomas M, Rose, George W, Bush, Kelly Bagby, Bagby, Amgen, Donald Trump, Karine Jean, Pierre, Biden, Jean, we'll, Becerra, Feldman Organizations: Senate, AbbVie Inc, AstraZeneca, Myers Squibb Co, Janssen Pharmaceuticals, Johnson, Merck & Co, Inc, Pfizer, Sanofi, Getty, U.S . Chamber of Commerce, Bristol Myers Squibb, Washington , D.C, Southern, Southern District of, Democratic Party, U.S, Merck, Bristol, Pharmaceutical Research, Manufacturers of America, CNBC, Medicare, University of California College of, Justice Department, Michigan Gov, Bristol Myers, Human Services, Centers, Services, AARP Foundation, HHS, AARP, Specialty Pharmacy, Reuters, Supreme, Appeals, Democratic, U.S . Sixth, Republican, Third, White Locations: America, Washington , DC, Bristol, U.S, Washington ,, Southern District, Southern District of Ohio, New Jersey, Commerce's Dayton , Ohio, San Francisco
☆ Why U.S. purchase of radiation sickness drug Nplate is no cause for alarm
  + stars: | 2022-10-07 | by ( Https | Media-Cldnry.S-Nbcnews.Com Image Upload Newscms Berkeley-Lovelace-Jr.Jpg | Berkeley Lovelace Jr. | ) www.nbcnews.com   time to read: +3 min
Amid concerns about Russian President Vladimir Putin’s recent nuclear threats came a bit of startling news: The U.S. Department of Health and Human Services said Tuesday that it spent $290 million on a drug to treat radiation sickness. Nplate, manufactured by U.S. drugmaker Amgen, was approved by the Food and Drug Administration in 2021 to treat injuries caused by acute radiation syndrome, also known as radiation sickness. Amgen will maintain the supply of the drug, an approach the HHS says lowers costs for taxpayers and allows the drug to be used in the commercial market before it expires. Chris Meekins, former deputy assistant secretary for preparedness and response at HHS, said that he sees no cause for alarm over the purchase. Greg Burel, the former director of the Strategic National Stockpile, agreed, saying that he doesn't think the HHS' purchase of the drug is related to the Russian invasion of Ukraine in February.
0 next >>
Total: 2